Medicare Needs ‘Robust’ Claims Oversight So Inflation Rebates Won’t Duplicate 340B Discounts
Executive Summary
PhRMA urges CMS to take a more proactive approach to monitoring 340B claims than previously proposed. Meanwhile, hospitals object to the claims modifier requirement.